SEC Filing Summary: Greatbatch, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Greatbatch, Inc. on February 11, 2008. The filing reports a material corporate event under Item 8.01 (Other Events) and includes financial statement exhibits under Item 9.01. Note: The request metadata referenced "Integer Holdings Corp," but the filing text explicitly identifies the registrant as Greatbatch, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the completion of a strategic acquisition rather than periodic financial performance.
Material Changes
- Acquisition Completion: On February 11, 2008, Precimed, S.A., an indirect wholly-owned subsidiary of Greatbatch, Inc., completed the acquisition of the DePuy Orthopaedics manufacturing facility located in Chaumont, France.
- Announcement: The company issued a press release (attached as Exhibit 99.1) to disclose this transaction.
Guidance, Outlook, and Risks
The filing text does not contain updated financial guidance, management commentary on future outlook, specific risk factors, or details regarding contingencies related to this transaction. The document serves strictly as a notification of the event's completion.
Investor Verification Checklist
- Verify the strategic rationale and financial terms of the Chaumont, France facility acquisition in the attached press release (Exhibit 99.1).
- Confirm the impact of this acquisition on Greatbatch's future manufacturing capacity and orthopaedic product portfolio.
- Review subsequent quarterly reports (10-Q) or annual reports (10-K) for the financial integration results of the Precimed, S.A. subsidiary.